Stone Daniel E. 13D and 13G filings for BiondVax Pharmaceuticals Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-10-06 10:23 am Purchase | 2022-09-19 | 13G | BiondVax Pharmaceuticals Ltd. BVXV | Stone Daniel E. | 3,748,852 5.020% | 3,748,852 (New Position) | Filing |